Q1 Earnings Forecast for OPCH Issued By Barrington Research

Option Care Health, Inc. (NASDAQ:OPCH) – Stock analysts at Barrington Research boosted their Q1 2025 EPS estimates for Option Care Health in a research note issued on Tuesday, January 14th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $0.22 for the quarter, up from their previous forecast of $0.20. Barrington Research currently has a “Outperform” rating and a $33.00 target price on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.21 per share. Barrington Research also issued estimates for Option Care Health’s Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.32 EPS, Q4 2025 earnings at $0.36 EPS, FY2025 earnings at $1.20 EPS and FY2026 earnings at $1.42 EPS.

OPCH has been the subject of a number of other research reports. JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Truist Financial decreased their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Finally, Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the company from $26.00 to $33.00 in a research report on Monday. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $29.86.

Option Care Health Stock Performance

Shares of NASDAQ OPCH opened at $28.76 on Thursday. The company has a market cap of $4.89 billion, a P/E ratio of 24.17, a P/E/G ratio of 2.44 and a beta of 1.31. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm’s fifty day moving average is $23.33 and its two-hundred day moving average is $27.70.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. American Century Companies Inc. boosted its position in Option Care Health by 0.5% in the 2nd quarter. American Century Companies Inc. now owns 1,154,215 shares of the company’s stock valued at $31,972,000 after buying an additional 5,614 shares during the period. Federated Hermes Inc. grew its stake in Option Care Health by 5.5% in the second quarter. Federated Hermes Inc. now owns 20,621 shares of the company’s stock worth $571,000 after purchasing an additional 1,073 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Option Care Health by 15.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 65,075 shares of the company’s stock worth $1,803,000 after purchasing an additional 8,695 shares during the period. Envestnet Asset Management Inc. raised its position in Option Care Health by 2.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 231,315 shares of the company’s stock valued at $6,407,000 after purchasing an additional 6,283 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA purchased a new stake in shares of Option Care Health in the 2nd quarter worth $68,003,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.